Paper Details

  1. Home
  2. Paper Details

Intravenous immunoglobulin for post-polio syndrome: a randomised controlled trial.

Author: BorgKristian, GonzalezHenrik, KaponidesGeorgios, OlssonTomas, SjöbergInger, SunnerhagenKatharina Stibrant

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

The study investigated the use of intravenous immunoglobulin in post-polio syndrome, given the underlying inflammatory process indicated by proinflammatory cytokines within the CNS.
Paper Details　
Original Abstract of the Article :
Survivors of poliomyelitis often develop increased or new symptoms decades after the acute infection, known as post-polio syndrome. Production of proinflammatory cytokines within the CNS indicates an underlying inflammatory process, accessible for immunomodulatory treatment. We did a multicentre, ra...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/S1474-4422(06)70447-1

データ提供：米国国立医学図書館（NLM）

Intravenous Immunoglobulin for Post-Polio Syndrome: A New Oasis in Treatment

The aftermath of polio infection can be long-lasting and debilitating, much like a desert that has been ravaged by a storm. This research explores the potential benefits of intravenous immunoglobulin (IVIG) in treating post-polio syndrome, a condition that can develop decades after the initial infection. The study focuses on the underlying inflammatory process in the central nervous system (CNS) and its potential responsiveness to immunomodulatory treatments like IVIG. The researchers conducted a randomized controlled trial, a rigorous approach akin to carefully examining different paths in a desert to find the most effective route.

The Promise of IVIG in Post-Polio Treatment

The study's findings suggest that IVIG may be a promising treatment for post-polio syndrome, potentially offering relief from the debilitating symptoms associated with this condition. This research provides a glimmer of hope in the vast and unforgiving desert of post-polio research, offering a potential avenue for improving the lives of individuals affected by this condition.

A New Oasis in Post-Polio Treatment

This study holds promise for the development of new and effective treatments for post-polio syndrome, offering a beacon of hope in the vast desert of post-polio research. By exploring the potential of IVIG and other immunomodulatory therapies, we can strive to improve the lives of individuals affected by this condition and provide them with greater relief from their symptoms.

Dr.Camel's Conclusion

This research delves into the potential benefits of intravenous immunoglobulin in treating post-polio syndrome, offering a new oasis of hope in the desert of this debilitating condition. By carefully examining the underlying inflammatory process and exploring the effectiveness of immunomodulatory treatments, we can strive to provide greater relief and support to those affected by post-polio syndrome.

Date :
  1. Date Completed 2006-07-13
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

16713921

DOI: Digital Object Identifier

10.1016/S1474-4422(06)70447-1

Related Literature

Article Analysis
・Effective treatment of post-polio syndrome
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.